Body radiation exposure in breast cancer radiotherapy: Impact of breast IMRT and virtual wedge compensation techniques

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 1, 2006, Pages 52-58

  Woo, Tony C S ^a   Pignol, Jean Philippe ^a   Rakovitch, Eileen ^a   Vu, Toni ^a   Hicks, Deanna ^a   O'Brien, Peter ^a   Pritchard, Kathleen ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Anthracyclines; Breast neoplasms; Combined modality therapy; IMRT; Leukemia; Radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; MEDICAL IMAGING; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

ANTHRACYCLINES; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; IMRT; LEUKEMIA;

DOSIMETRY;

ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION EXPOSURE; STANDARDIZATION; WHOLE BODY RADIATION;

BODY HEIGHT; BODY WEIGHT; BREAST NEOPLASMS; FEMALE; HUMANS; LEUKEMIA, RADIATION-INDUCED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; SCATTERING, RADIATION;

EID: 33646008861     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.11.023     Document Type: Article

References (37)

1. Howe H.L., Wingo P.A., Thun M.J., et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93 (2001) 824-842
2. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
3. Bartelink H., Horiot J.C., Poortmans P., et al., European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
4. Desobry G.E., Waldron T.J., and Das I.J. Validation of a new virtual wedge model. Med Phys 25 (1998) 71-72
5. Kestin L.L., Sharpe M.B., Frazier R.C., et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy. Initial clinical experience. Int J Radiat Oncol Biol Phys 48 (2000) 1559-1568
6. Van Asselen B., Raaijmakers C.P., Hofman P., and Lagendijk J.J. An improved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother Oncol 58 (2001) 341-347
7. Monson J.M., Chin L., Nixon A., et al. Is machine energy (4-8 MV) associated with outcomes for Stage I-II breast cancer patients?. Int J Radiat Oncol Biol Phys 37 (1997) 1095-1100
8. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
9. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
10. Giordano S.H., Kuo Y.-F., Freeman J.L., et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97 (2005) 419-424
11. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer. A population-based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
12. Rubino C., de Vathaire F., Diallo I., Shamsaldin A., and Le M.G. Increased risk of second cancers following breast cancer. Role of the initial treatment. Breast Cancer Res Treat 61 (2000) 183-195
13. Kaplan H.G., Malmgren J.A., and Atwood M. Leukemia incidence following primary breast carcinoma treatment. Cancer 101 (2004) 1529-1536
14. Crump M., Tu D., Shepherd L., Levine M., Bramwell V., and Pritchard K. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy. A report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21 (2003) 3066-3071
15. Smith R.E., Bryant J., DeCillis A., Anderson S., and National Surgical Adjuvant Breast and Bowel Project Experience. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer. The National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 21 (2003) 1195-1204
16. Bonneterre J., Roche H., Kerbrat P., et al. Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer. 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial. J Clin Oncol 23 (2005) 2686-2693
17. Therasse P., Mauriac L., Welnicka-Jaskiewicz M., et al., EORTC. Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer. An EORTC-NCIC-SAKK multicenter study. J Clin Oncol 21 (2003) 843-850
18. Curtis R.E., Boice Jr. J.D., Stovall M., et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326 (1992) 1745-1751
19. Delwail V., Jais J.P., Colonna P., and Andrieu J.M. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. Br J Haematol 118 (2002) 189-194
20. Hong L., Hunt M., Chui C., et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 44 (1999) 1155-1164
21. De Meerleer G.O., Derie C.M., Vakaet L., Fortan L.G., Mersseman Jr. B.K., and De Neve W.J. Execution of a single-isocenter three-field technique, using a multileaf collimator or tray-mounted cerrobend blocks. Effect on treatment time. Int J Radiat Oncol Biol Phys 39 (1997) 255-259
22. Hamers H.P., Johansson K.A., Venselaar J.L., de Brouwer P., Hansson U., and Moudi C. Entrance and exit TL-dosimetry in the conservative treatment of breast cancer. A pilot study for the EORTC-Radiotherapy Cooperative Group. Radiother Oncol 22 (1991) 280-284
23. Pierce D.A., Shimizu Y., Preston D.L., Vaeth M., and Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer. 1950-1990. Radiat Res 146 (1996) 1-27
24. Preston D.L., Kusumi S., Tomonaga M., et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 137 (1994) S68-S97
25. van Leeuwen F.E., Klokman W.J., Hagenbeek A., et al. Second cancer risk following Hodgkin's disease. A 20-year follow-up study. J Clin Oncol 12 (1994) 312-325
26. Swerdlow A.J., Barber J.A., Hudson G.V., et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort. The relation to age at treatment. J Clin Oncol 18 (2000) 498-509
27. van Leeuwen F.E., Stiggelbout A.M., van den Belt-Dusebout A.W., et al. Second cancer risk following testicular cancer. A follow-up study of 1,909 patients. J Clin Oncol 11 (1993) 415-424
28. National Research Council Committee on the Biological Effects of Ionizing Radiations. Health effects of exposure to low level of radiation. BEIR V report (1990), Academic Press, Washington, DC 242-252
29. Chang S.X., Deschesne K.M., Cullip T.J., Parker S.A., and Earnhart J. A comparison of different intensity-modulation treatment techniques for tangential breast irradiation. Int J Radiat Oncol Biol Phys 45 (1999) 1305-1314
30. Magne N., Marcie S., Pignol J.P., Casagrande F., and Lagrange J.L. Radiotherapy for a solitary brain metastasis during pregnancy. A method for reducing fetal dose. Br J Radiol 74 (2001) 638-641
31. Mazonakis M., Varveris H., Damilakis J., Theoharopoulos N., and Gourtsoyiannis N. Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 55 (2003) 386-391
32. Summary of recommendations. In: Smith R.E. (Ed). 1990 Recommendations of the International Commission on Radiological Protection (1990) 67-77 ICRP Publication Vol. 60 Oxford, U.K.: Pergamon Press
33. Prasad K.N., Cole W.C., and Haase G.M. Radiation protection in humans. Extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage. Br J Radiol 77 (2004) 97-99
34. Owen J.B., Coia L.R., and Hanks G.E. The structure of radiation oncology in the United States in 1994. Int J Radiat Oncol Biol Phys 39 (1997) 179-185
35. Shibuya H., and Tsujii H. The structural characteristics of radiation oncology in Japan in 2003. Int J Radiat Oncol Biol Phys 62 (2005) 1472-1476
36. Ruggieri-Pignon S., Pignon T., Marty M., Rodde-Dunet M.H., Destembert B., and Fritsch B. Infrastructure of radiation oncology in France. A large survey of evolution of external-beam radiotherapy practice. Int J Radiat Oncol Biol Phys 61 (2005) 507-516
37. Esco R., Palacios A., Pardo J., et al., Spanish Society of Radiotherapy Oncology. Infrastructure of radiotherapy in Spain. A minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys 56 (2003) 319-327